We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA TELLS ASTRAZENECA TO HALT CRESTOR DTC ADS
FDA TELLS ASTRAZENECA TO HALT CRESTOR DTC ADS
December 30, 2004
AstraZeneca has received a letter from the FDA’s Division of Drug Marketing, Advertising, and Communications (DDMAC) citing the firm’s safety claims for its cholesterol-lowering drug Crestor, which the agency has deemed false and misleading.